Skip to main content
. 2017 Sep 18;7:11751. doi: 10.1038/s41598-017-11843-4

Figure 2.

Figure 2

In vitro and ex vivo dose-response activity of the CyC analogs against M. tb H37Rv. (A) Activity of CyC 7(α), CyC 7(β), CyC 17, and CyC 18(β) against GFP-expressing M. tb replicating in broth medium, expressed as normalized relative fluorescence units (RFU%). (B) Activity of CyC 7(α) and CyC 7(β) against M. tb replicating inside Raw264.7 macrophages. Results are expressed as the percentage of infected macrophages after 5 days post-infection. For each concentration, data are means ± SD of at least two independent assays performed in duplicate. The MIC50 of CyC 17, CyC 18(β), CyC 7(β) and CyC 7(α) replicating in culture broth medium were 0.5 μM, 1.7 µM, 16.6 µM and 92.6 μM, respectively. The MIC50 of CyC 7(α) and CyC 7(β) replicating inside macrophages were 4.5 μM and 3.1 μM, respectively. Values are means ± SD of three independent assays performed in triplicate (CV% < 5%).